FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:538-539 August 12, 1999 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Bonenkamp, J.J. PubMed Citation

To the Editor: The results of the randomized trial comparing extended (D2) and limited (D1) lymph-node dissection for gastric cancer, reported by Bonenkamp et al. (March 25 issue),¹ should be interpreted with caution. Patients in the D2 group had a higher in-hospital death rate than those in the D1 group. It has already been suggested that the learning curve and protocol design (removal of the pancreatic tail in patients with a proximal tumor who were undergoing a D2 dissection) account for the difference.² The high percentage of in-hospital deaths in the D2 group might have introduced a bias in the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Pacelli, F., Papa, V., Rosa, F., Tortorelli, A. P., Sanchez, A. M., Covino, M., Bossola, M., Doglietto, G. B. (2008). Four Hundred Consecutive Total Gastrectomies for Gastric Cancer: A Single-Institution Experience. Arch Surg 143: 769-775 [Abstract] [Full Text]  
• Doglietto, G. B., Pacelli, F., Caprino, P., Bossola, M., Stasi, C. D. (2000). Pancreas-Preserving Total Gastrectomy for Gastric Cancer. Arch Surg 135: 89-92 [Abstract] [Full Text]